about
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).Beyond the monofilament for the insensate diabetic foot: a systematic review of randomized trials to prevent the occurrence of plantar foot ulcers in patients with diabetesDiabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement ...Intensification of insulin therapy in patients with type 2 diabetes mellitus: an algorithm for basal-bolus therapyRecommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profileShort and longer term outcomes of a diabetes disease management program in underserved Latino patientsType 1 diabetes through the life span: a position statement of the American Diabetes AssociationManagement of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of DiabetesCardiovascular effects of intensive lifestyle intervention in type 2 diabetes.The relationship of social support with treatment adherence and weight loss in Latinos with type 2 diabetes.Incretin-based therapies: review of current clinical trial data.Intensive weight loss intervention in older individuals: results from the Action for Health in Diabetes Type 2 diabetes mellitus trial.Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.Do experiences consistent with a medical-home model improve diabetes care measures reported by adult Medicaid patients?"We are all gonna get diabetic these days": the impact of a living legacy of type 2 diabetes on Hispanic young adults' diabetes care.The Look AHEAD Trial: bone loss at 4-year follow-up in type 2 diabetes.Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.Challenges contributing to disrupted transition from paediatric to adult diabetes care in young adults with type 1 diabetesConsiderations for treating dyslipidemia in special diabetic populations.Male anorgasmia treated with oxytocin.Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes.Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry.Patient perspectives on peer mentoring: type 1 diabetes management in adolescents and young adults.Primary care medical home experience and health-related quality of life among adult medicaid patients with type 2 diabetes.Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.Long-term outcomes of a Web-based diabetes prevention program: 2-year results of a single-arm longitudinal studyUnderstanding the sources of diabetes distress in adults with type 1 diabetes.Let's Empower and Prepare (LEAP): Evaluation of a Structured Transition Program for Young Adults With Type 1 Diabetes.Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 InhibitionEffect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial.Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular DiseaseAssociation between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis.Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population.Cost-effective screening for diabetic retinopathy using a nonmydriatic retinal camera in a prepaid health-care setting.The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older.Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.Continuous glucose monitoring pilot in low-income type 1 diabetes patients.Cardiovascular health: associations with race-ethnicity, nativity, and education in a diverse, population-based sample of CaliforniansClinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM).
P50
Q22241288-4FAEA5FA-EAE0-4984-B486-5745D2D36F28Q24632375-D45A51D7-5408-44B3-AE6B-E2DC6F8EF2CFQ26865504-80CB0A53-9905-499D-B90B-55904E9603B7Q27001931-09F9FA8E-2393-47E6-81AE-F729DD9219C0Q27687563-9F5AD7A4-6A09-4547-B8CE-F6B7F769FE73Q28194040-6F081056-42FF-4205-A2AB-D97022273F61Q28242092-51C1DA7E-CECB-40ED-8FA9-31B948D4E45CQ28254549-F6961F5B-9595-4B60-850D-067481B1C76DQ30548796-A3FF8BA8-41A4-4686-9B46-FADA9BF92863Q30719169-64297B84-3329-4315-BC7A-8E12647B1900Q33537570-EF332D3F-C252-4FC2-AC28-90D20B3DE64FQ34010035-6002C82A-F13E-46A8-96A3-3CCCEE6AFBACQ34073450-B12C7971-F453-4051-A321-DD7D0CEE533AQ34073494-5E7226F0-5C89-4C75-B74C-51EAA9EE0BAEQ34214446-09B826FB-84D0-4198-ADD1-1E1570424F47Q34219386-D1C3DCDC-C9A5-4BC6-AA7D-FEC6C69DFBFEQ34457919-C4CFADC9-BA4A-4E17-AE95-C86AD6F8177AQ34459281-380C0EB7-22D7-480F-8C22-D1E6FDA0CB54Q34627378-67E158A1-274C-42C5-84F0-B910A7B580D5Q34726517-667F3791-33B4-4E3C-B4D1-8CBA2B65E651Q34746369-9D6B91BF-8AEA-4986-9853-B836B04332B4Q34768952-D23D2018-2E86-4A3A-BC81-79DECFF17D15Q35009757-837079E6-8CC8-4A57-AB59-ADDD2FDD9E58Q35040363-FBC1C730-2669-4573-B215-7F80ACE54BBAQ35060170-92C9DA8B-F541-490A-AB8F-E9E97E2719B7Q35360823-5111C288-949B-403D-81E6-F16258809E88Q35537662-415B6D2F-FF2C-4E2B-ACD5-3595D8AA8A80Q35554617-BC5D9B16-73DC-465C-A458-1FA816987350Q35881430-47DF24E8-6FCE-437D-A8CA-B8969AFBE12CQ35973255-7CC99D92-F8AE-46ED-BEBE-ECDE49CE692EQ36133698-35687C1E-3810-4766-ACE9-18857BCE8403Q36153812-467865BC-406E-417F-BA92-0C5C000D31ADQ36350029-BE7A392C-CD08-4F41-964F-7C51AAD86C85Q36444054-BD2D907B-3AB8-4079-AC56-9808CF386E89Q36769844-C2E1E499-0695-4ADF-8168-7603854C37F8Q37054706-CBC6F3DB-9AD4-4317-B6D8-2EDFE933775BQ37151277-DC2DF2A9-FC7B-44B5-9396-D295FF7D177EQ37192472-AC07653C-8A2D-4849-A908-5A6ECACC227CQ37224960-8D18D3C4-A776-4DC8-A9E2-62E2760DE632Q37242652-8E121AD2-FC4F-4565-B000-5F763B394CE4
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anne L. Peters
@ast
Anne L. Peters
@en
Anne L. Peters
@es
Anne L. Peters
@nl
type
label
Anne L. Peters
@ast
Anne L. Peters
@en
Anne L. Peters
@es
Anne L. Peters
@nl
altLabel
Anne Harmel
@en
Anne L. Peters
@en
prefLabel
Anne L. Peters
@ast
Anne L. Peters
@en
Anne L. Peters
@es
Anne L. Peters
@nl
P106
P1153
7402105843
P21
P31
P496
0000-0003-0520-0776